Last updated: 11/07/2018 05:00:11
Burden of HER2-positive breast cancer with brain metastases
GSK study ID
112717
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Burden of HER2-positive breast cancer with brain metastases
Trial description: Burden of HER2-positive breast cancer with brain metastases
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Sandrine B, Paul C, Youlia K, Florence M, Cécile S, Thomas B, Emilie Le R, Christelle L, Maya G, Nicolas M, Cristian M, Bruno C, Dominique S, Daniel S, François-Emery C, Laure B, Cathie M, Sabine Laulhere-Vigneau, Isabelle Durand-Zaleski. TREATMENT PATTERNS, CLINICAL OUTCOMES AND HEALTH CARE COSTS ASSOCIATED WITH HER2-POSITIVE BREAST CANCER WITH CENTRAL NERVOUS SYSTEM METASTASES: A FRENCH MULTICENTRE OBSERVATIONAL STUDY. BMC Health Serv Res. 2013;13(456)
Medical condition
Neoplasms
Product
lapatinib
Collaborators
Not applicable
Study date(s)
July 2010 to February 2011
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
No study documents available.
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2011-11-02
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website